KOSDAQ - Delayed Quote KRW

ABION Inc. (203400.KQ)

6,480.00
+430.00
+(7.11%)
At close: 3:30:30 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
759,683.81
759,683.81
1,274,306.82
2,506,519.18
1,638,498.05
Cost of Revenue
537,179.36
537,179.36
1,258,465.07
1,786,558.41
1,535,160.83
Gross Profit
222,504.45
222,504.45
15,841.75
719,960.77
103,337.22
Operating Expense
34,288,262
34,288,262
31,177,331
25,886,842
10,774,969
Operating Income
-34,065,757.55
-34,065,757.55
-31,161,489.25
-25,166,881.23
-10,671,631.78
Net Non Operating Interest Income Expense
-3,123,994.87
-3,123,994.87
-1,558,987.28
519,197.46
-1,387,869.55
Pretax Income
-43,381,471.01
-43,381,471.01
-29,210,914.23
-19,925,392.20
-54,254,205.23
Tax Provision
--
--
--
--
4,851.09
Net Income Common Stockholders
-43,381,471.01
-43,381,471.01
-29,210,914.23
-19,925,392.20
-54,259,056.32
Basic EPS
-1.80k
--
-1.52k
-1.06k
-3.75k
Diluted EPS
-1.80k
--
-1.52k
-1.06k
-3.75k
Basic Average Shares
24,100.82
--
19,167.27
18,815.29
14,457.52
Diluted Average Shares
24,100.82
--
19,167.27
18,815.29
14,457.52
Total Operating Income as Reported
-34,065,757.01
-34,065,757.01
-31,251,887.85
-25,166,881.83
-10,671,631.78
Rent Expense Supplemental
13,503
13,503
11,843
42,119
34,837
Total Expenses
34,825,441.36
34,825,441.36
32,435,796.07
27,673,400.41
12,310,129.83
Net Income from Continuing & Discontinued Operation
-43,381,471.01
-43,381,471.01
-29,210,914.23
-19,925,392.20
-54,259,056.32
Normalized Income
-37,845,598.01
-37,845,598.01
-32,946,501.23
-23,825,509.20
-44,144,319.32
Interest Income
128,231
128,231
524,494
1,228,322
429,317
Interest Expense
3,252,227
3,252,227
2,083,481
709,124
1,817,187
Net Interest Income
-3,123,994.87
-3,123,994.87
-1,558,987.28
519,197.46
-1,387,869.55
EBIT
-40,129,244.01
-40,129,244.01
-27,127,433.23
-19,216,268.20
-52,437,018.23
EBITDA
-39,599,276.01
-39,599,276.01
-26,579,187.23
-18,719,116.20
-51,935,001.23
Reconciled Cost of Revenue
537,179.36
537,179.36
1,258,465.07
1,786,558.41
1,535,160.83
Reconciled Depreciation
529,967.45
529,967.45
548,244.31
497,150.51
502,016.83
Net Income from Continuing Operation Net Minority Interest
-43,381,471.01
-43,381,471.01
-29,210,914.23
-19,925,392.20
-54,259,056.32
Total Unusual Items Excluding Goodwill
-5,535,873
-5,535,873
3,735,587
3,900,117
-13,486,316
Total Unusual Items
-5,535,873
-5,535,873
3,735,587
3,900,117
-13,486,316
Normalized EBITDA
-34,063,403.01
-34,063,403.01
-30,314,774.23
-22,619,233.20
-38,448,685.23
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-3,371,579
12/31/2021 - 4/5/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

344860.KQ INNOGENE Co.,Ltd.
2,585.00
+25.18%
 
000504.SZ Landfar Bio-medicine Co., Ltd
6.77
+1.50%
 
7774.T Japan Tissue Engineering Co., Ltd.
591.00
-2.31%
 
130A.T VERITAS IN SILICO INC
640.00
-1.08%
 
475960.KQ TOMOCUBE
29,200.00
+9.36%
 
CONCORDBIO.BO Concord Biotech Limited
1,500.15
-0.40%
 
086900.KQ Medy-Tox Inc.
168,200.00
+2.56%
 
4565.T Nxera Pharma Co., Ltd.
834.00
-2.11%
 
302440.KS SK bioscience Co.,Ltd.
40,200.00
+0.50%
 
347850.KQ D&D Pharmatech
89,600.00
-0.11%